Research Progress on Biomarkers of the Depression

Abstract

Due to the increasing number of individuals suffering from depression, there is much attention paid to the detection of depression. This review paper addresses the critical field of depression detection, examining innovative methods including serological tests, cerebrospinal fluid analysis, and imaging techniques. Serological markers like C-reactive protein and cytokines are highlighted for their potential in identifying inflammation associated with depression. The role of cerebrospinal fluid in providing direct brain markers is discussed, alongside the utility of imaging in visualizing brain metabolism linked to depressive symptoms. Though there is a large amount of evidence, more and further research is still needed, which ensures that these methods are more quantitative and precise enough so that we can put them into practice. The overview and understanding of these approaches are crucial to improving diagnostic precision, which is quite essential for developing effective treatment strategies and enhancing patient outcomes in the management of depression.